Designs for Single- or Multiple-Agent Phase I Trials (Q3445286): Difference between revisions

From MaRDI portal
Import240304020342 (talk | contribs)
Set profile property.
ReferenceBot (talk | contribs)
Changed an Item
Property / cites work
 
Property / cites work: A Random Walk Rule for Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Confidence interval estimation subject to order restrictions / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design and Analysis of Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose Finding Using the Biased Coin Up-and-Down Design and Isotonic Regression / rank
 
Normal rank
Property / cites work
 
Property / cites work: Practical Bayesian Guidelines for Phase IIB Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding with Two Agents in Phase I Oncology Trials / rank
 
Normal rank

Revision as of 19:59, 25 June 2024

scientific article
Language Label Description Also known as
English
Designs for Single- or Multiple-Agent Phase I Trials
scientific article

    Statements

    Identifiers